Compumedics Limited (ASX:CMP)

40.0¢

right-arrow Created with Sketch. 0 (0%)
MCAP $70.86M
Last trade 14.25pm 21/01/2022 20mins delayed

Latest Announcements

18/01/2022CMPCompumedics Limited
12/01/2022 Price SensitivePSCMPCompumedics Limited
12/01/2022 Price SensitivePSCMPCompumedics Limited
1,202
MCap
10/01/2022 Price SensitivePSCMPCompumedics Limited
1,471
MCap
17/12/2021 Price SensitivePSCMPCompumedics Limited
08/12/2021 Price SensitivePSCMPCompumedics Limited
28/10/2021CMPCompumedics Limited
2,943
MCap
28/10/2021CMPCompumedics Limited
354
MCap

Company Overview

Compumedics Limited is an Australia-based medical device company. The Company is engaged in development, manufacture and commercialization of diagnostics technology for the sleep, brain and ultrasonic blood-flow monitoring applications. The Company sells all its product offerings, including sleep diagnostic systems, clinical EEG systems, brain monitoring systems, ultra-sonic blood-flow systems, supplies and technical service and support. The Company sell its products throughout America’s, Australia and Asia Pacific, and Europe and the Middle East regions. Its United States business also includes sleep diagnostic services business. The Company product includes ONsight A.V.S., Grael PSG, Grael LT EEG System, Siesta 802, Grael 4K PSG:EEG, Grael 4K-EEG, Neuvo 64-512 Channel LTM EEG and CURRY. The Company’s subsidiaries include Compumedics USA Ltd, DWL USA Inc., Compumedics USA Inc, Compumedics Telemed Pty Ltd, Compumedics Medical Innovation Pty Ltd, Compumedics Cardiology Pty Ltd.

CMP in the news

Compumedics (CMP) has received clearance from the U.S. Food and Drug Administration…
New technology for brain scanning in epilepsy treatment and pre-surgical brain mappingInstalled…

Search Previous Announcements